Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults

Clinical trial NCT06782958 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06782958
Sponsor: Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
Status: ENROLLING_BY_INVITATION
Phase: Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis (ALS)

Start date: 2024-07-05
Primary completion: 2025-03-03
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.